Brief Report: SWOG S1400D (), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

Brief Report: SWOG S1400D (), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously-treated Patients with Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thoracic oncology 2019-06, Vol.14 (10), p.1847-1852
Hauptverfasser: Aggarwal, Charu, Redman, Mary W., Lara, Primo N., Borghaei, Hossein, Hoffman, Philip, Bradley, Jeffrey D., Newman, Alfred J., Feldman, Marvin J., Minichiello, Katherine, Miao, Jieling, Mack, Philip C., Papadimitrakopoulou, Vassiliki A., Herbst, Roy S., Kelly, Karen, Gandara, David R.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1556-0864
1556-1380
DOI:10.1016/j.jtho.2019.05.041